Prevalence of prediabetes and undiagnosed diabetes in Canada (2007-2011) according to fasting plasma glucose and HbA1c screening criteria

Diabetes Care

Volumn 38, Issue 7, 2015, Pages 1299-1305

  Rosella, Laura C ^a,b,c   Lebenbaum, Michael ^b   Fitzpatrick, Tiffany ^b   Zuk, Aleksandra ^a   Booth, Gillian L ^d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b PUBLIC HEALTH ONTARIO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CANADA; CHILD; CROSS-SECTIONAL STUDY; DIABETES POPULATION RISK TOOL; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE SURVEY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRACTICE GUIDELINE; PREDICTIVE VALUE; PREVALENCE; RISK ASSESSMENT; SCREENING; SEX DIFFERENCE; WAIST CIRCUMFERENCE; ANALYSIS; BLOOD; DIABETES MELLITUS, TYPE 2; DIET RESTRICTION; MASS SCREENING; MIDDLE AGED; PREDIABETIC STATE; PRESCHOOL CHILD; PROCEDURES; STANDARDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CANADA; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MASS SCREENING; MIDDLE AGED; PREDIABETIC STATE; PREVALENCE; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84949467172     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-2474     Document Type: Article

References (37)

1. Canadian Diabetes Association. Diabetes: Canada at the Tipping Point. Toronto, Canadian Diabetes Association, 2011
2. Goeree R, Lim ME, Hopkins R, et al. Prevalence, total and excess costs of diabetes and related complications in Ontario, Canada. Can J Diabetes 2009;33:35-45
3. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993;328:1676-1685
4. Young TK, Mustard CA. Undiagnosed diabetes: does it matter? CMAJ 2001;164:24-28
5. Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev 2000;16:230-236
6. Koopman RJ, Mainous AG 3rd, Liszka HA, et al. Evidence of nephropathy and peripheral neuropathy in US adults with undiagnosed diabetes. Ann Fam Med 2006;4:427-432
7. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992;15:815-819
8. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
9. Gannon MC, Nuttall FQ. Control of blood glucose in type 2 diabetes without weight loss by modification of diet composition. Nutr Metab (Lond) 2006;3:16
10. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA 2002;287:360-372
11. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl. 1):S62-S69
12. Wilson SE, Rosella LC, Lipscombe LL, Manuel DG. The effectiveness and efficiency of diabetes screening in Ontario, Canada: a population-based cohort study. BMC Public Health 2010;10:506
13. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 2006;29:1263-1268
14. Greiver M, Aliarzadeh B, Moineddin R, Meaney C, Ivers N. Diabetes screening with hemoglobin A1c prior to a change in guideline recommendations: prevalence and patient characteristics. BMC Fam Pract 2011;12:91
15. Hunt KJ, Gebregziabher M, Egede LE. Racial and ethnic differences in cardiometabolic risk in individuals with undiagnosed diabetes: National Health and Nutrition Examination Survey 1999-2008. J Gen Intern Med 2012;27:893-900
16. Rosella LC, Manuel DG, Burchill C, Stukel TA; PHIAT-DM team. A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT). J Epidemiol Community Health 2011;65:613-620
17. Pottie K, Jaramillo A, Lewin G, et al, .; Canadian Task Force on Preventive Health Care. Recommendations on screening for type 2 diabetes in adults. CMAJ 2012;184:1687-1696
18. 1c and fasting plasma glucose: National Health and Nutrition Examination Surveys, 1999-2010. Diabetes Care 2013;36:2286-2293
19. Boltri JM, Okosun IS, Davis-Smith M, Vogel RL. Hemoglobin A1c levels in diagnosed and undiagnosed black, Hispanic, and white persons with diabetes: results from NHANES 1999-2000. Ethn Dis 2005;15:562-567
20. Kirk JK, Passmore LV, Bell RA, et al. Disparities in A1C levels between Hispanic and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care 2008;31:240-246
21. 1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction: a 6-year community-based prospective study. Diabetes Care 2011;34:944-949
22. 1c in identifying and predicting diabetes: the strong heart study. Diabetes Care 2011;34:363-368
23. Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS. Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care 2010;33:2184-2189
24. Nomura K, Inoue K, Akimoto K. A two-step screening, measurement of HbA1c in association with FPG, may be useful in predicting diabetes. PLoS One 2012;7:e36309
25. Sacks DB. A1C versus glucose testing: a comparison. Diabetes Care 2011;34:518-523
26. Statistics Canada. Canadian Health Measures Survey (CHMS) Data Users Guide: Cycle 2 [Internet]. Ottawa, ON, Canada, Statistics Canada, 2012. Available from data.library.utoronto.ca/datapub/codebooks/cstdli/chms/CHMS-User-Guide-Cycle2-E.pdf. Accessed 20 March 2014
27. Rosella LC, Corey P, Stukel TA, Mustard C, Hux J, Manuel DG. The influence of measurement error on calibration, discrimination, and overall estimation of a risk prediction model. Popul Health Metr 2012;10:20
28. Abbasi A, Peelen LM, Corpeleijn E, et al. Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study. BMJ 2012;345:e5900
29. Mortaz S, Wessman C, Duncan R, Gray R, Badawi A. Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation. Clinicoecon Outcomes Res 2012;4:91-97
30. Gregg EW, Cadwell BL, Cheng YJ, et al. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. Diabetes Care 2004;27:2806-2812
31. Leong A, Dasgupta K, Chiasson JL, Rahme E. Estimating the population prevalence of diagnosed and undiagnosed diabetes. Diabetes Care 2013;36:3002-3008
32. Demmer RT, Zuk AM, Rosenbaum M, Desvarieux M. Prevalence of diagnosed and undiagnosed type 2 diabetes mellitus among US adolescents: results from the continuous NHANES, 1999?-2010. Am J Epidemiol 2013;178:1106-1113
33. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009;32:287-294
34. James C, Bullard KM, Rolka DB, et al. Implications of alternative definitions of prediabetes for prevalence in U.S. adults. Diabetes Care 2011;34:387-391
35. Mann DM, Carson AP, Shimbo D, Fonseca V, Fox CS, Muntner P. Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults. Diabetes Care 2010;33:2190-2195
36. Mainous AG 3rd, Tanner RJ, Baker R, Zayas CE, Harle CA. Prevalence of prediabetes in England from 2003 to 2011: population-based, cross-sectional study. BMJ Open 2014;4:e005002
37. Frank EA, Shubha MC, D'Souza CJ. Blood glucose determination: plasma or serum? J Clin Lab Anal 2012;26:317-320